Spiro(2H-isoindole-2,1′-piperazinium), 4′-(1,2-benzisothiazol-3-yl)octahydro-, (3aR,7aR)-, methanesulfonate (1:1) (CAS No: 186204-37-5) is a key pharmaceutical intermediate used in the synthesis of APIs Lurasidone. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: Lurasidone Impurity 23, Lurasidone mesylate intermediate
CAS No: 186204-37-5
PubChem CID: 71578599
Mol Formula: C20H29N3O3S2
Mol Weight: 423.6 g/mol
Used in API: Lurasidone
IUPAC Name: 3-[(3aR,7aR)-spiro[1,3,3a,4,5,6,7,7a-octahydroisoindol-2-ium-2,4'-1,4-diazinan-4-ium]-1'-yl]-1,2-benzothiazole;methanesulfonate
API Intermediate Description: Spiro(2H-isoindole-2,1'-piperazinium), 4'-(1,2-benzisothiazol-3-yl)octahydro-, (3aR,7aR)-, methanesulfonate (1:1) is a chemical compound characterized by a spiro linkage between an isoindole and piperazinium ring system, with a benzisothiazole substituent and associated as a methanesulfonate salt. It is notable for its structural features involving strong hydrogen bonding and aromatic stacking interactions, contributing to its stability and potential bioactivity.
